SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons
4 references·16 citing·29 second hop
MDMA-induced neurotoxicity: Parameters of degeneration and recovery of brain serotonin neurons (1988)MDMA-induced neurotoxicity: Parameters of…Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. (1987)Neurotoxicity of the psychede…Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. (1987)Biochemical and histological …3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. (1987)3,4-Methylenedioxymethampheta…Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals (1985)Hallucinogenic Amphetamine Se…Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview (2009)Molecular and Cellular Mechan…3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings (2006)3,4-Methylenedioxymethampheta…Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [11C]McN5652 and [11C]DASB (2005)Quantitative PET Studies of t…Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function (2004)Acute and long-term effects o…Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms (2003)Methylenedioxymethamphetamine…Altered states: the clinical effects of Ecstasy (2003)Altered states: the clinical …Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users (2003)Acute, sub‐acute and long‐ter…Cortical Serotonin Transporter Density and Verbal Memory in Individuals Who Stopped Using 3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy") (2001)Cortical Serotonin Transporte…Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) (2000)Impaired cognitive performanc…(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals (2000)(±)3,4-Methylenedioxymethamph…Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study (1999)Cognitive performance in (±) …3,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans (1999)3,4-Methylenedioxy analogues …The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (`ecstasy') (1998)The relationship between the …3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans (1994)3,4‐Methylenedioxymethampheta…Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”) (1990)Neurochemistry and Neurotoxic…Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites (1988)Pharmacologic profile of MDMA…Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens (1986)Mood and cognitive effects of ± 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’): week‐end ‘high’ followed by mid‐week low (1997)Recreational Use of “Ecstasy” (MDMA) Is Associated with Elevated Impulsivity (1998)Memory deficits associated with recreational use of "ecstasy" (MDMA) (1999)Positron emission tomographic evidence of toxic effect of MDMA (“Ecstasy”) on brain serotonin neurons in human beings (1998)Hallucinogens (2004)Residual neurocognitive features of long‐term ecstasy users with minimal exposure to other drugs (2010)In Vivo Imaging of Cerebral Serotonin Transporter and Serotonin2A Receptor Binding in 3,4-Methylenedioxymethamphetamine (MDMA or “Ecstasy”) and Hallucinogen Users (2011)3,4-methylenedioxymethamphetamine (MDMA): current perspectives (2013)Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984)Effects of enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices (1986)Acute Psychological Effects of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”) are Attenuated by the Serotonin Uptake Inhibitor Citalopram (2000)Serotonin Neurotoxicity after (±)3,4-Methylenedioxymethamphetamine (MDMA; “Ecstasy”): A Controlled Study in Humans (1994)Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance (1998)The relative contributions of ecstasy and cannabis to cognitive impairment (2000)Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? (2001)Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior (1983)Working Memory (1992)Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies (2001)Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: A multiple regression analysis (2004)Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy (2005)Recreational MDMA use in Sydney: a profile of ‘Ecstasy’ users and their experiences with the drug (1992)Psychological and Cardiovascular Effects and Short-Term Sequelae of MDMA (“Ecstasy”) in MDMA-Naïve Healthy Volunteers (1998)Ecstasy (MDMA): a review of its possible persistent psychological effects (2000)Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users. (1988)Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research (2001)Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity (2002)Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users (2000)Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)
this work references cited by second hop

References

  • 1987Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.530 cited
  • 19873,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.458 cited
  • 1987Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain.453 cited
  • 1985Hallucinogenic Amphetamine Selectively Destroys Brain Serotonin Nerve Terminals367 cited

Cited by

  • 2000Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)306 cited
  • 1988Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites301 cited
  • 1999Cognitive performance in (±) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study300 cited
  • 2000(±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Studies in Animals292 cited
  • 2009Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview291 cited
  • 19943,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”): pharmacology and toxicology in animals and humans289 cited
  • 20063,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings266 cited
  • 1998The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA (`ecstasy')242 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2005Quantitative PET Studies of the Serotonin Transporter in MDMA Users and Controls Using [11C]McN5652 and [11C]DASB204 cited
  • 2003Methylenedioxymethamphetamine (MDMA, Ecstasy) neurotoxicity: cellular and molecular mechanisms199 cited
  • 2001Cortical Serotonin Transporter Density and Verbal Memory in Individuals Who Stopped Using 3,4-Methylenedioxymethamphetamine (MDMA or "Ecstasy")191 cited
  • 2003Altered states: the clinical effects of Ecstasy190 cited
  • 1990Neurochemistry and Neurotoxicity of 3,4‐Methylenedioxymethamphetamine (MDMA, “Ecstasy”)183 cited
  • 19993,4-Methylenedioxy analogues of amphetamine: Defining the risks to humans178 cited
  • 2003Acute, sub‐acute and long‐term subjective consequences of ‘ecstasy’ (MDMA) consumption in 430 regular users171 cited
  • 2004Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function153 cited